Stock IZAFE B IZAFE GROUP AB
Add to a list
To use this feature you must be a member
Log inSign up

Financials iZafe Group AB

Equities

IZAFE B

SE0003656834

Advanced Medical Equipment & Technology

Delayed Nasdaq Stockholm
Other stock markets
 03:57:35 18/06/2024 pm IST 		5-day change 1st Jan Change
0.222 SEK 0.00% Intraday chart for iZafe Group AB +3.74% -22.92%
26/04 IZafe Group AB Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
15/04 IZafe Group AB Announces Ida Almgren to Step Down as CFO , Effective June 18, 2024 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 87.71 51.39 97.32 57.33 24.14 72.17
Enterprise Value (EV) 1 107.5 54.86 95.52 43.59 26.44 68.86
P/E ratio -7 x -1.98 x -7.52 x -1.03 x -0.99 x -2.07 x
Yield - - - - - -
Capitalization / Revenue 11.6 x 3.59 x 10.9 x 153 x 33.1 x 39.6 x
EV / Revenue 14.2 x 3.83 x 10.7 x 116 x 36.3 x 37.8 x
EV / EBITDA -10.6 x -2.61 x -3.68 x -1.31 x -1.15 x -5.05 x
EV / FCF -6.38 x -3.75 x -3.51 x -2.69 x -1.95 x -13.5 x
FCF Yield -15.7% -26.6% -28.5% -37.2% -51.3% -7.39%
Price to Book 8.78 x 1.81 x 3.31 x 1.41 x 1.15 x 2.85 x
Nbr of stocks (in thousands) 14,449 22,297 32,769 70,871 82,947 2,50,586
Reference price 2 6.070 2.305 2.970 0.8090 0.2910 0.2880
Announcement Date 03/04/19 25/05/20 06/05/21 08/04/22 05/04/23 30/04/24
1SEK in Million2SEK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 7.571 14.33 8.904 0.375 0.729 1.822
EBITDA 1 -10.17 -21.06 -25.96 -33.23 -22.98 -13.64
EBIT 1 -10.74 -22.03 -26.68 -33.27 -23.12 -20.39
Operating Margin -141.84% -153.73% -299.64% -8,873.07% -3,171.88% -1,118.94%
Earnings before Tax (EBT) 1 -11.13 -23.2 -12.84 -36.28 -23.59 -35.72
Net income 1 -11.31 -23.12 -12.75 -36.28 -23.53 -32.18
Net margin -149.41% -161.33% -143.24% -9,673.33% -3,227.16% -1,765.92%
EPS 2 -0.8673 -1.164 -0.3949 -0.7843 -0.2942 -0.1388
Free Cash Flow 1 -16.85 -14.62 -27.19 -16.2 -13.55 -5.09
FCF margin -222.6% -102.02% -305.39% -4,320.93% -1,858.8% -279.36%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 03/04/19 25/05/20 06/05/21 08/04/22 05/04/23 30/04/24
1SEK in Million2SEK
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 19.8 3.47 - - 2.3 -
Net Cash position 1 - - 1.8 13.7 - 3.31
Leverage (Debt/EBITDA) -1.944 x -0.1648 x - - -0.1 x -
Free Cash Flow 1 -16.9 -14.6 -27.2 -16.2 -13.6 -5.09
ROE (net income / shareholders' equity) -106% -98.3% -38.4% -103% -59% -100%
ROA (Net income/ Total Assets) -23.4% -23.9% -31.2% -49.8% -29.2% -29.9%
Assets 1 48.28 96.83 40.86 72.83 80.69 107.7
Book Value Per Share 2 0.6900 1.280 0.9000 0.5700 0.2500 0.1000
Cash Flow per Share 2 0.0800 0.2600 0.0800 0.2600 0.0100 0.0200
Capex 1 1.66 1.23 0.72 0.21 - -
Capex / Sales 21.93% 8.58% 8.03% 57.07% - -
Announcement Date 03/04/19 25/05/20 06/05/21 08/04/22 05/04/23 30/04/24
1SEK in Million2SEK
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
IZAFE GROUP AB Stock iZafe Group AB
-22.92% 58.18L
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+7.01% 22TCr
DANAHER CORPORATION Stock Danaher Corporation
+9.85% 19TCr
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+27.51% 15TCr
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+31.79% 11TCr
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
-0.84% 6.28TCr
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+13.93% 5.23TCr
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
+1.85% 4.93TCr
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+0.30% 3.54TCr
RESMED, INC. Stock ResMed, Inc.
+22.28% 3.09TCr
Other Advanced Medical Equipment & Technology
  1. Stock Market
  2. Equities
  3. IZAFE B Stock
  4. Financials iZafe Group AB